3rd Circ. Won't Rethink Girardi Keese Avandia Fee
By Alex Wolf ( July 27, 2015, 4:44 PM EDT) -- The Third Circuit on Monday denied The Girardi Keese Law Firm's bid for a full-bench rehearing of a decision ordering the firm to give $10 million in GlaxoSmithKline LLC settlement money to a common benefit fund in centralized suits against GlaxoSmithKline LLC over the diabetes drug Avandia....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.